Serveur d'exploration Tocilizumab

Attention, ce site est en cours de développement !
Attention, site généré par des moyens informatiques à partir de corpus bruts.
Les informations ne sont donc pas validées.

Eléments de l'association

Auvergne-Rhône-Alpes99
M. Soubrier5
Auvergne-Rhône-Alpes Sauf M. Soubrier" 96
M. Soubrier Sauf Auvergne-Rhône-Alpes" 2
Auvergne-Rhône-Alpes Et M. Soubrier 3
Auvergne-Rhône-Alpes Ou M. Soubrier 101
Corpus6869
\n\n\n\n \n

List of bibliographic references

Number of relevant bibliographic references: 3.
Ident.Authors (with country if any)Title
001C76 C. Giraud [France] ; Z. Tatar [France] ; M. Soubrier [France]Agranulocytosis under biotherapy in rheumatoid arthritis: three cases hypothesis of parvovirus B19 involvement in agranulocytosis observed under tocilizumab and rituximab for the treatment of rheumatoid arthritis
002F10 I. Castrejon [États-Unis] ; T. Pincus [États-Unis] ; M. Soubrier [France] ; Y. C. Lin [États-Unis] ; M. Dougados [France]FRI0077 Relative efficiencies of joint counts and laboratory tests are no higher than patient-reported measures to document superior results in the guepard tight-control versus espoir routine care cohorts
003218 M. Couderc [France] ; S. Mathieu [France] ; M. Soubrier [France]AB0310 Predictive factors for the response to rituximab in rheumatoid arthritis: Results from a french university hospital

Wicri

This area was generated with Dilib version V0.6.34.
Data generation: Fri May 22 09:34:00 2020. Site generation: Sun Mar 28 09:01:19 2021